SoftOx Solutions AS — AGM Information 2022

Dec 2, 2022

SoftOx Solutions AS: Notice of Extraordinary General Meeting

SoftOx Solutions AS: Notice of Extraordinary General Meeting

• Current CEO Geir Almås proposed as new chairman of SoftOx Solutions AS

• Three additional board members proposed - Henrik Nielsen, Adrian Bignami and Jørgen Berggrav

Oslo, Norway – 2 December 2022: The board of directors of SoftOx Solutions AS ("SoftOx" or the "Company"), a medtech and clinical-stage pharmaceutical company based in Oslo, Norway, hereby convenes, upon the request of certain large shareholders (including the CEO, Geir Almås), an extraordinary general meeting to be held on 9 December 2022 for the election of a new chairman and new board members.

The notice to the EGM and the proposal from the shareholders are attached. A summary of the shareholders proposal is included in the following:

"After several major achievements in the past half year including the European Defence Fund grant and successful completion of Phase 1 of the SoftOx Biofilm Eradicator, the Company’s largest shareholders, representing 26 per cent of the total number of outstanding shares, have proposed changes to the current Board of Directors and management team. The shareholder group, including Dinge Invest AS, Hermod Farms AS, Kristian Almås, Almhaug Bolig AS, all companies associated with Kristian and Geir Almås, proposes that CEO Geir Hermod Almås step down from his current role as CEO and transition to chairman of SoftOx.

To further strengthen both the board of directors and management team, the shareholder group proposes the addition of Henrik Nielsen, Adrian Bignami and Jørgen Berggrav as elected members of the board. Together with the existing members Kari Myren and Olav Jarlsby, the new members will represent an international board with interests and expertise reflective of the company’s current and future business pursuits.

Henrik J. Nielsen is the founder and CEO of CAP Partner, a conference handling and consulting firm based in Frederiksberg, Denmark, and Director of the European Wound Management Association, which is one of the largest not-for-profit umbrella organisations in the world within the field of scientific and clinical wound care. Nielsen is an expert in association management, advocacy, fundraising and organization and has provided many years of expertise in the medical device area as a consultant.

Adrian Bignami is one of the early co-inventors of the SoftOx technology and is currently the Vice President of Finance, Business Planning and Analysis at C4 Therapeutics, Inc., a clinical-stage biotechnology company in the US. He has over 20 years of experience in management consulting, investment banking, entrepreneurship, business development and corporate finance across the pharmaceutical and biotechnology sectors.

Jørgen Berggrav (Rear Admiral Rtd) has served as the Senior Advisor of SoftOx Defense Solutions since September 2022. Berggrav has held many diverse roles in the Armed Forces including as Director General in the Ministry of Defence, representative of Europe to the Supreme Allied Commander Transformation and representative of the Chief of Defence at NATO’s operational command, SHAPE.

SoftOx Solutions AS hereby calls for an Extraordinary General Meeting (EGM) to be held at Martin Linges vei 25, 1364 Fornebu on 9 December 2022 at 12:00 hours (CET). Shareholders are encouraged to submit proxies with or without voting instructions in advance of the general meeting."

Shareholders wishing to attend the Extraordinary General Meeting, in person or by proxy, must complete and return the attendance form or proxy form to the SoftOx IR email ir@soft-ox.com no later than 8 December 2022 at 12:00.

The notice of the EGM is attached. All documents regarding the EGM are also available on the Company’s website: https://soft-ox.com/stock-market-announcements/

The following items are on the agenda: (i) Election of new Chair of the Board of

Directors and changes to the board (ii) Remuneration to the chair of the board and board members.

For further information, please contact:

Geir Almås, CEO of SoftOx Solutions AS

Mail: ir@soft-ox.com

Phone: Front Desk: (+47) 948-59-599

About SoftOx Solutions AS

SoftOx Solutions AS (SoftOx, listed on Euronext Growth Oslo) is a medtech and clinical-stage pharmaceutical company based in Oslo, Norway, with the goal of reducing the spread of infection and emergence of antimicrobial resistance.

For more information on SoftOx, visit www.soft-ox.com